Release Date: 29/04/09 11:09 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 819KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%